PharmD Info

A forum for Indian Pharmacy Professionals

Discuss various Doctor of Pharmacy Knowledge based topics
  • User avatar
#647
Sun Pharma, India’s largest drug maker by market share, said one of its sub-sidiaries plans to acquire US-based InSite
Vision, a company that develops specialty ophthalmic, or eye care drugs. The deal,with an equity value of $48 million in addi-tion to related debt and transaction costs, is expected to help build Sun’s branded oph-thalmology products portfolio in the US.
Attachments:
1.jpg
1.jpg (1.15 MiB) Viewed 642 times
Last bumped by Prajith on 12 Dec 2015, 13:01.

Tags

It's very important to know the various resources […]

It is a most expected proposal from PCI to include[…]

Free online courses are listed which are more suit[…]

Applications are invited for a postgraduate fello[…]

WELCOME TO OUR E-LEARN COURSE WORK MODULES